Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 102

Evolv graduates to $1.25bn reverse merger

Motorola Solutions is among the participants supplying $300m in PIPE financing as the contactless security system developer agrees to list through a reverse takeover.

Mar 10, 2021

DTCP accepts Axonius stake in $270m deal

Deutsche Telekom-backed DTCP was among a group of investors that acquired a $270m stake in the cybersecurity management platform developer in a secondary transaction.

Mar 10, 2021

Edgewise nears $100m IPO

Novo will exit the musculoskeletal disease drug developer, should the latter complete an initial public offering on the Nasdaq Global Market.

Mar 10, 2021

Design Therapeutics decides to go public

SR One is line for an exit from the small-molecule therapy developer, which has raised $170m in venture funding in the past year.

Mar 10, 2021

Quench Bio dismantles business

Max Planck spinout Quench Bio will wind down after its target proved undruggable and will return capital to investors, which include AbbVie Ventures.

Mar 10, 2021

Quench Bio ends operations

Quench Bio will wind down after its protein target proved undruggable and will return capital to investors including AbbVie Ventures.

Mar 10, 2021

Xero zeroes in on Planday acquisition

Metro Group is among the shareholders set to exit the employee management platform developer in an acquisition by accounting technology producer Xero.

Mar 9, 2021

IonQ signs up to $2bn reverse merger

Hyundai, Kia and GV are contributing to a $350 PIPE in support of a reverse merger that will value the Maryland and Duke-linked company at $2bn.

Mar 9, 2021

IonQ signs up to $2bn reverse merger

Hyundai, Kia and existing investor GV are contributing to a $350 PIPE in support of a reverse takeover that will value the merged company at $2bn.

Mar 9, 2021

Olo sets $324m IPO goal

The PayPal-backed food ordering software provider is slated to raise between $228m and $324m after setting a range for its initial public offering.

Mar 9, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here